Literature DB >> 33170043

The Relationship Between Gastroesophageal Reflux Disease and Laryngopharyngeal Reflux Based on pH Monitoring.

Yun Wu1, Junyao Wang1, Qing Huang1, Tao Peng1, Lili Zhao1, Guijian Feng1, Yulan Liu1.   

Abstract

OBJECTIVES: Many studies on the relationship between gastroesophageal reflux disease (GERD) and laryngopharyngeal reflux (LPR) were based on symptoms, but there are few research on it using reflux monitoring. This study was designed to investigate the relationship between GERD and LPR based on pH monitoring.
METHODS: All patients were scheduled for esophageal manometry and pH monitoring sequentially. They were stratified into 4 groups as no reflux disease, isolated GERD, isolated LPR (iLPR), and GERD combined with LPR (GERD&LPR) according to pH monitoring.
RESULTS: The incidence of LPR in GERD was 46.3%, while the probability of combining GERD in LPR was 52.7%. The reflux profile in the laryngopharynx showed a significant difference in the total reflux time (17.82 ± 18.4 vs 9.62 ± 9.58, P = .023) and the percentage of total reflux time (1.31% ± 1.37% vs 0.71% ± .0.73%, P = .023) between the GERD&LPR and iLPR groups.
CONCLUSION: Laryngopharyngeal reflux can be combined with GERD or it can exist as an independent diagnosis. In patients with GERD&LPR, the total reflux time and the percentage of reflux time in the laryngopharynx are higher than those in the iLPR group. Reflux episodes in the laryngopharynx of patients with GERD&LPR may be derived from GERD.

Entities:  

Keywords:  esophageal pH monitoring; gastroesophageal reflux; laryngopharyngeal pH monitoring; laryngopharyngeal reflux

Mesh:

Year:  2020        PMID: 33170043     DOI: 10.1177/0145561320971915

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  1 in total

1.  Prevalence of reflux-related symptoms in South-Hungarian blood donor volunteers.

Authors:  Krisztina Helle; Lenke Bálint; Veronika Szekeres; Georgina Ollé; András Rosztóczy
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.